Which has stronger earnings and valuation, ALVOW or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $491.95M N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is ALVOW or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A Aravive N/A N/A N/A

Which has higher valuation and earnings, APLMW or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apollomics $8.50M N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is APLMW or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets Apollomics N/A N/A N/A Aravive N/A N/A N/A

Which has higher earnings & valuation, BIAFW or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio bioAffinity Technologies $5.85M N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is BIAFW or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets bioAffinity Technologies N/A N/A N/A Aravive N/A N/A N/A

Which has stronger valuation & earnings, ARAV or BIVIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aravive N/A N/A N/A -$0.90 N/A BioVie N/A N/A N/A N/A N/A

Is ARAV or BIVIW more profitable?

Company Net Margins Return on Equity Return on Assets Aravive N/A N/A N/A BioVie N/A N/A N/A

Which has preferable valuation & earnings, CDIOW or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cardio Diagnostics $14.45K N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is CDIOW or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets Cardio Diagnostics N/A N/A N/A Aravive N/A N/A N/A

Aravive (ARAV) Competitors

$0.04 0.00 (0.00%)

As of 10/2/2026

Compare

ARAV vs. ALVOW, APLMW, BIAFW, BIVIW, and CDIOW

Should you buy Aravive stock or one of its competitors? Aravive's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), bioAffinity Technologies (BIAFW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Aravive compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$491.95M	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

In the previous week, Alvotech had 3 more articles in the media than Aravive. MarketBeat recorded 3 mentions for Alvotech and 0 mentions for Aravive. Alvotech's average media sentiment score of 1.05 beat Aravive's score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company	Overall Sentiment
Alvotech	Positive
Aravive	Neutral

Summary

Alvotech beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Aravive compare to Apollomics?

Apollomics (NASDAQ:APLMW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

Company	Net Margins	Return on Equity	Return on Assets
Apollomics	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apollomics	$8.50M	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Apollomics' average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company	Overall Sentiment
Apollomics	Neutral
Aravive	Neutral

Summary

Aravive beats Apollomics on 2 of the 3 factors compared between the two stocks.

How does Aravive compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

Company	Net Margins	Return on Equity	Return on Assets
bioAffinity Technologies	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
bioAffinity Technologies	$5.85M	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

In the previous week, bioAffinity Technologies had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for bioAffinity Technologies and 0 mentions for Aravive. Aravive's average media sentiment score of 0.00 beat bioAffinity Technologies' score of -0.78 indicating that Aravive is being referred to more favorably in the news media.

Company	Overall Sentiment
bioAffinity Technologies	Negative
Aravive	Neutral

Summary

Aravive beats bioAffinity Technologies on 3 of the 5 factors compared between the two stocks.

How does Aravive compare to BioVie?

Aravive (NASDAQ:ARAV) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aravive	N/A	N/A	N/A	-$0.90	N/A
BioVie	N/A	N/A	N/A	N/A	N/A

In the previous week, Aravive's average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score.

Company	Overall Sentiment
Aravive	Neutral
BioVie	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Aravive	N/A	N/A	N/A
BioVie	N/A	N/A	N/A

Summary

Aravive beats BioVie on 2 of the 2 factors compared between the two stocks.

How does Aravive compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk.

In the previous week, Cardio Diagnostics' average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company	Overall Sentiment
Cardio Diagnostics	Neutral
Aravive	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardio Diagnostics	$14.45K	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
Cardio Diagnostics	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

Summary

Aravive beats Cardio Diagnostics on 2 of the 3 factors compared between the two stocks.

Get Aravive News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARAV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ARAV vs. The Competition

Export

Metric	Aravive	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$3.85B	$7.14B	$13.26B
Dividend Yield	N/A	3.65%	2.53%	17.36%
P/E Ratio	-0.04	12.99	274.34	26.20
Price / Sales	N/A	1,293.73	614.18	95.18
Price / Cash	N/A	39.04	27.22	34.70
Price / Book	N/A	17.34	11.34	6.40
Net Income	N/A	-$23.20M	$3.49B	$381.07M
7 Day Performance	N/A	-2.11%	-1.27%	-0.28%
1 Month Performance	N/A	-10.19%	-5.94%	-4.51%
1 Year Performance	N/A	17.45%	7.29%	1.63%

Aravive Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ALVOW Alvotech	N/A	$0.38 flat	N/A	-69.7%	$0.00	$491.95M	N/A	4	News Coverage Positive News
APLMW Apollomics	N/A	$0.01 +2.8%	N/A	N/A	$0.00	$8.50M	N/A	15	Positive News Gap Up
BIAFW bioAffinity Technologies	N/A	$0.34 +19.6%	N/A	+11.5%	$0.00	$5.85M	N/A	10	Gap Up
BIVIW BioVie	N/A	$0.32 +14.3%	N/A	N/A	$0.00	N/A	N/A	13	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ARAV) was last updated on 10/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aravive (ARAV) Competitors